Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.

Benzer Materyaller

• Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.
  Yazar:: Thadepalli, H, ve diğerleri
  Baskı/Yayın Bilgisi: (1986)
• In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
  Yazar:: Thadepalli, H, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Splenic abscess caused by Shigella flexneri and Bacteroides fragilis.
  Yazar:: Drow, D L, ve diğerleri
  Baskı/Yayın Bilgisi: (1984)
• In vivo effects of rufloxacin and ciprofloxacin on T-cell subsets and tumor necrosis factor production in mice infected with Bacteroides fragilis.
  Yazar:: Gollapudi, S V, ve diğerleri
  Baskı/Yayın Bilgisi: (1993)
• Microbial synergy in experimental intra-abdominal abscess.
  Yazar:: Onderdonk, A B, ve diğerleri
  Baskı/Yayın Bilgisi: (1976)